Table: Kyowa Kirin -2024 parent results
Feb 6 (Reuters)-
Kyowa Kirin Co., Ltd.
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Dec 31, 2024 Dec 31, 2023 Dec 31, 2025 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 286.51 277.16
(+3.4 pct) (+9.2 pct)
Operating loss 4.62 53.43
(+31.5 pct)
Recurring 68.61 67.22
(+2.1 pct) (+80.3 pct)
Net 60.67 50.37
(+20.4 pct) (+62.2 pct)
EPS 114.57 yen 93.70 yen
EPS Diluted 114.57 yen 93.69 yen
Ann Div 58.00 yen 56.00 yen 60.00 yen
-Q2 Div 29.00 yen 27.00 yen 30.00 yen
-Q4 Div 29.00 yen 29.00 yen 30.00 yen
NOTE - Kyowa Kirin Co., Ltd..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4151.T
Recent news on Kyowa Kirin
See all newsFactbox: Global pharma companies that have publicly announced Trump drug pricing agreements
Factbox: Global pharma companies that have publicly announced Trump drug pricing agreements
Brief: Kyowa Kirin Announces Agreement With US Administration To Reduce Treatment Costs For Americans
Table: Kyowa Kirin 6-MTH group results (IFRS)
Brief: Kyowa Kirin Says European Commission Approves Crysvita For Infants With X-Linked Hypophosphataemia